Literature DB >> 728711

Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence?

R L Travers, G R Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728711      PMCID: PMC1608782          DOI: 10.1136/bmj.2.6151.1532-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Aspirin hepatitis.

Authors:  J D Wolfe; A L Metzger; R C Goldstein
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

2.  Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus.

Authors:  W E Seaman; K G Ishak; P H Plotz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

3.  Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.

Authors:  R R Rich; J S Johnson
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

4.  Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers.

Authors:  W E Seaman; P H Plotz
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

5.  Serum transaminases during salicylate therapy.

Authors:  A S Russell; R A Sturge; M A Smith
Journal:  Br Med J       Date:  1971-05-22
  5 in total
  4 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  [Not Available].

Authors:  J Y Lang
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

Review 3.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

Review 4.  Systemic lupus erythematosus: treatment and prognosis.

Authors:  G R Hughes
Journal:  Br Med J       Date:  1979-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.